← Eichor
Study identifier: NCT06386874 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment

Condition: Ischemic Stroke  ·  Sponsor: BrainQ Technologies Ltd.

PhaseNA
Planned participants122
Who can joinAll sexes, 22 Years to 80 Years
Healthy volunteersNo

About this study

This is a multicenter study that will be conducted at approximately 20 centers and up to 30 centers, if the sample size will be increased following interim assessment. The Q Therapeutic System (BQ 3.0) is a wearable medical device that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. The Q Therapeutic System (BQ 3.0) is indicated for adjunctive use in a clinical facility or home setting, in addition to standard-of-care therapies. * In Stage 1 (starting 4-21 days after the index stroke event to day 90 post stroke), participants will be randomly assigned (1:1) to receive either active or the sham treatments, up to 5 times a week, and at least to a total of 45 treatments. * In Stage 2 (day 90 to day 180 post stroke), participants in both the active and the control group will be allowed to continue to receive active treatments, up to 5 times per week. * In stage 3 (day 180 to day 270 post stroke), participants will not receive any treatments and would be followed up until the final visit at day 270. Each session will last approximately 60 minutes, with stimulation activated for up to 40 minutes, in conjunction with a home-based exercise program. Treatments may be administered in the hospital, in the clinic or in a home setting. The study will enroll 100-122 adult subjects who will be randomly assigned (1…

This description comes directly from the study's public registry record.

Talk to the study team

Assaf Lifshitz  ·  9720544586787  ·  assaf@brainqtech.com

Iren Basanov  ·  972526936695  ·  iren.basanov@brainqtech.com

Always discuss trial participation with your own doctor first.

Locations (14)

Rancho Research InstituteDowney, California, United StatesRecruiting
MedStar National Rehabililtaion Hospital,Washington D.C., District of Columbia, United StatesRecruiting
Brooks Rehabilitation HospitalJacksonville, Florida, United StatesNot Yet Recruiting
Emory University School of MedicineAltanta, Georgia, United StatesNot Yet Recruiting
Shirley Ryan AbilityLabChicago, Illinois, United StatesNot Yet Recruiting
KUMC- KU Medical CenterKansas City, Kansas, United StatesRecruiting
Hackensack Meridian JFK Johnson Rehabilitation InstituteEdison, New Jersey, United StatesRecruiting
Kessler Foundation for RehabilitationWest Orange, New Jersey, United StatesRecruiting
New York-Presbyterian Brooklyn Methodist Hospital Inpatient Rehabilitation UnitBrooklyn, New York, United StatesNot Yet Recruiting
Burke Rehabilitation HospitalWhite Plains, New York, United StatesRecruiting
Atrium Health Carolinas RehabilitationCharlotte, North Carolina, United StatesRecruiting
Moss Rehabilitation Research InstituteElkins Park, Pennsylvania, United StatesNot Yet Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06386874